News
SHANGHAI, CHINA / ACCESS Newswire / July 22, 2025 / Lingyi Biotech , a clinical-stage biotechnology company specializing in ...
Onlymyhealth on MSN14d
Diagnosed with Gaucher Disease At The Age of 5 months, Prajwal Now Shines as a State-Level Cricket StarDiscover how early diagnosis and enzyme replacement therapy helped Prajwal overcome Gauchers disease and shine in cricket ...
Treatment with ambroxol for symptoms of Parkinson’s disease dementia was safe, but its efficacy was undetermined in a small ...
Healthcare Asia Magazine on MSN12d
What factors drive the Asia Pacific’s Gaucher disease treatment market?The sector is expected to hit $553.8m by 2034. The growing integration of genetic testing into national healthcare frameworks ...
The list recommending customs duty of 5% includes 74 drugs, while another suggesting full exemption has 69 drugs. A separate ...
While GenomeIndia focuses on data and discovery, the UMMID aims to ensure that the benefits of genetic science reach every ...
The documents show that blockbuster cancer drugs like pembrolizumab (brand Keytruda), osimertinib (brand Tagrisso), and ...
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...
Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback